Literature DB >> 9382068

Noncirrhotic hepatoma presenting with paraneoplastic neurologic manifestations: two cases.

S Norris1, S Rajendiran, K Sheahan, S Murphy, D Royston, R Alyusuf, M Farrell, P A McCormick.   

Abstract

Hepatocellular carcinoma usually occurs in patients with cirrhosis and is rarely associated with paraneoplastic neurologic disorders. We describe two young patients with hepatomas occurring in noncirrhotic livers, both of whom presented with neurologic symptoms. A 19-yr-old man who presented with coma and a 23-yr-old woman with a 3-month history of progressive hemiparesis, dysarthria, and altered affect were each found, at autopsy, to have hepatocellular carcinoma occurring in a noncirrhotic liver. Neuropathologic examinations revealed widespread multifocal necrotizing leukoencephalopathy in the man and occlusive noninflammatory cerebral vasculopathy with widespread cortical and subcortical infarcts in the woman. It is unlikely that the neuropathologic findings in these patients are explicable on the basis of antibody-mediated tissue injury.

Entities:  

Mesh:

Year:  1997        PMID: 9382068

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  3 in total

1.  Hepatocellular carcinoma presenting with chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  M R Arguedas; B M McGuire
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

2.  Paraneoplastic coma and acquired central alveolar hypoventilation as a manifestation of brainstem encephalitis in a patient with ANNA-1 antibody and small-cell lung cancer.

Authors:  Kwan S Lee; Michaela J Higgins; Bhavesh M Patel; Joel S Larson; Mohamed Y Rady
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

3.  Severe digital ischemia coexists with thrombocytopenia in malignancy-associated antiphospholipid syndrome: A case report and review of literature.

Authors:  Jia-Lei Chen; Xi Yu; Rong Luo; Ming Liu
Journal:  World J Clin Cases       Date:  2021-12-26       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.